These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29917190)

  • 1. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
    Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
    Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
    Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
    World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer.
    Jia ZZ; Jiang GM; Feng YL
    Chin Med Sci J; 2011 Sep; 26(3):158-62. PubMed ID: 22207924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients.
    Shim JH; Park JW; Kim JH; An M; Kong SY; Nam BH; Choi JI; Kim HB; Lee WJ; Kim CM
    Cancer Sci; 2008 Oct; 99(10):2037-44. PubMed ID: 19016764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
    Ranieri G; Ammendola M; Marech I; Laterza A; Abbate I; Oakley C; Vacca A; Sacco R; Gadaleta CD
    World J Gastroenterol; 2015 May; 21(19):6018-25. PubMed ID: 26019468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization.
    Daniele A; Divella R; Quaranta M; Mattioli V; Casamassima P; Paradiso A; Garrisi VM; Gadaleta CD; Gadaleta-Caldarola G; Savino E; Maci R; Bellizzi A; Fazio V
    Clin Biochem; 2014 Feb; 47(3):184-90. PubMed ID: 24355694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
    Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
    ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations between serum hypoxia inducible factor-1α, vascular endothelial growth factor and computed tomography perfusion imaging at pre-and post-TACE in patients with primary hepatic carcinoma].
    Jia ZZ; Huang YQ; Feng YL; Jiang GM
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1472-5. PubMed ID: 24029570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
    Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
    Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the combination of serum levels of vascular endothelial growth factor, C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization.
    Xuan ZD; Zhou L; Wang Y; Zheng X
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1169-1178. PubMed ID: 29048943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
    Ishida H; Murata N; Tada M; Okada N; Hashimoto D; Kubota S; Shirakawa K; Wakasugi H
    Jpn J Clin Oncol; 2003 Apr; 33(4):186-91. PubMed ID: 12810833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
    Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
    Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.